Lars Fruergaard Jørgensen

Novo Nordisk Board Overhaul Amid Owner Conflict

The pharmaceutical giant Novo Nordisk is replacing almost the entire board of directors. An owner conflict is said to be behind the mass resignation.

Novo Nordisk to Cut 9,000 Jobs Amid Organizational Changes

The pharmaceutical giant Novo Nordisk is cutting its workforce by 9,000 positions. 5,000 of these affect the company's Danish operations. We are in a shock phase, says a union representative.

US Stock Markets Surge with Gains Across Major Indexes

Novo Nordisk CEO Lars Fruergaard Jørgensen Steps Down Amid Stock Drop

The Danish pharmaceutical giant Novo Nordisk's CEO Lars Fruergaard Jørgensen is leaving his post, according to a press release from the company. A certain connection to the share price drop is hinted at by the board as the reason.